Your browser doesn't support javascript.
loading
Implanted synthetic cells trigger tissue angiogenesis through de novo production of recombinant growth factors.
Chen, Gal; Levin, Rotem; Landau, Shira; Kaduri, Maya; Adir, Omer; Ianovici, Iris; Krinsky, Nitzan; Doppelt-Flikshtain, Ofri; Shklover, Jeny; Shainsky-Roitman, Janna; Levenberg, Shulamit; Schroeder, Avi.
Afiliação
  • Chen G; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
  • Levin R; The Interdisciplinary Program for Biotechnology, Technion, Haifa 32000, Israel.
  • Landau S; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
  • Kaduri M; Department of Biomedical Engineering, Technion, Haifa 32000, Israel.
  • Adir O; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
  • Ianovici I; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
  • Krinsky N; The Norman Seiden Multidisciplinary Program for Nanoscience and Nanotechnology, Technion, Haifa 32000, Israel.
  • Doppelt-Flikshtain O; Department of Biomedical Engineering, Technion, Haifa 32000, Israel.
  • Shklover J; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
  • Shainsky-Roitman J; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
  • Levenberg S; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.
  • Schroeder A; The Luis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa 32000, Israel.
Proc Natl Acad Sci U S A ; 119(38): e2207525119, 2022 09 20.
Article em En | MEDLINE | ID: mdl-36095208
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização Fisiológica / Células Artificiais / Fatores de Crescimento de Fibroblastos Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização Fisiológica / Células Artificiais / Fatores de Crescimento de Fibroblastos Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel